糖皮质激素受体高表达与前列腺癌侵袭性特征、早期生化复发及遗传不稳定性相关
该研究基于17,747例根治性前列腺切除术后组织芯片,免疫组化检测GR表达。GR高表达与高pT分期、高Gleason分级、淋巴结转移、切缘阳性及早期生化复发显著相关(p<0.0001),多因素分析显示其预后价值独立于pT、Gleason分级、pN和R状态。GR高表达还与TMPRSS2:ERG融合及高AR表达相关,ARpos/GRpos癌症预后最差。
要点
- GR高表达与前列腺癌侵袭性特征及早期生化复发独立相关。
- ARpos/GRpos组合提示最差预后,ARneg/GRneg预后最佳。
- GR免疫组化或可辅助识别高进展风险患者。
核心结论
- GR高表达与前列腺癌侵袭性在单因素和多因素分析中均强相关。
- GR免疫组化单独或联合其他标志物有潜力识别高肿瘤进展风险患者。
研究设计与样本
- 组织芯片包含17,747例前列腺癌,伴随访和分子数据,采用免疫组化分析。
- 所有患者均接受根治性前列腺切除术。
主要发现
- 12,125例可判读肿瘤中10,832例(89.1%)GR免疫染色阳性,其中48.5%弱、29.8%中、11%强染色。
- GR染色增强与高pT分期、高经典和定量Gleason分级、淋巴结转移(pN+)、切缘阳性(R1)及早期生化复发强相关(每项p<0.0001)。
- 多因素分析显示强GR染色的预后价值独立于pT、Gleason分级、pN和R状态。
- 高GR染色与TMPRSS2:ERG融合(p<0.0001)和高雄激素受体表达(p<0.0001)显著相关。
- GR和AR联合分析显示ARneg/GRneg癌症预后最佳,ARpos/GRpos癌症预后最差(p<0.0001);高GR表达在AR低、中、高癌症中均为不良预后强预测因子(每项p<0.0001)。
临床怎么用
- GR免疫组化或可与其他标志物联合用于前列腺癌风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The glucocorticoid receptor (GR) is a nuclear receptor protein for cortisol and other glucocorticoids and regulates the transcription of thousands of genes involved in metabolism, development, stress and inflammatory response. In prostate cancer, GR may confer resistance to anti-androgen receptor therapies by bypassing AR blockade. However, only few data are available on the prognostic role of GR expression in prostate cancer. METHODS: To estimate the prognostic value of GR, a tissue microarray containing 17,747 prostate cancers with associated follow-up and molecular data was analyzed by immunohistochemistry. RESULTS: All patients had undergone radical prostatectomy. GR immunostaining was found in 10,832 (89.1%) of 12,125 interpretable tumors, including 48.5% with weak, 29.8% with moderate and 11% with strong staining intensity. Increased GR staining was strongly linked to adverse feature of the disease, including high tumor stage (pT), high classical and quantitative Gleason grade, presence of nodal metastases (pN+), a positive surgical margin (R1) status, and early biochemical recurrence (p < 0.0001 each). A multivariate analysis showed that the prognostic value of strong GR staining was independent of pT, Gleason grade, pN and R status. High level GR staining was significantly linked to TMPRSS2:ERG fusion (p < 0.0001) and high androgen receptor expression (p < 0.0001 each). A combined analysis of the impact of GR and AR on patient prognosis identified the best prognosis for ARneg/GRneg cancers while ARpos/GRpos cancers showed the worst prognosis (p < 0.0001). Moreover, high GR expression was a strong predictor of poor prognosis in AR low, AR intermediate and AR high cancers (p < 0.0001 each). CONCLUSION: High level expression of GR is strongly linked to prostate cancer aggressiveness in uni- and multivariate analysis. GR immunohistochemistry - alone or in combination with other markers - holds great potential to identify patients with a high risk for tumor progression.
引用
- Heckmann N, Plage H, Simon R, et al. High level expression of glucocorticoid receptor (GR) is linked to aggressive tumor features, early biochemical recurrence, and genetic instability in prostate cancer. Prostate Cancer Prostatic Dis. 2025. PMID: 41188544. doi:10.1038/s41391-025-01046-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。